Canada markets closed

Xenetic Biosciences, Inc. (XBIO)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
4.0899+0.3199 (+8.49%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
2,540
2,540
1,707
1,161
436.942
Operating Expenses
Research Development
3,495
3,495
4,771
3,163
1,731
Selling General and Administrative
3,561
3,561
3,654
3,744
3,400
Total Operating Expenses
7,056
7,056
8,425
6,907
5,131
Operating Income or Loss
-4,516
-4,516
-6,718
-5,747
-4,695
Total Other Income/Expenses Net
25.38
25.38
-1.597
1.119
-9,244
Income Before Tax
-4,135
-4,135
-6,552
-5,645
-13,812
Income Tax Expense
-
-
-
0
-2,919
Income from Continuing Operations
-4,135
-4,135
-6,552
-5,645
-10,893
Net Income
-4,135
-4,135
-6,552
-5,645
-10,893
Net Income available to common shareholders
-4,135
-4,135
-6,552
-5,645
-10,893
Basic EPS
-2.90
-
-4.61
-5.50
-17.00
Diluted EPS
-2.90
-
-4.61
-5.50
-17.00
Basic Average Shares
1,520
-
1,422
1,028
639.238
Diluted Average Shares
1,520
-
1,422
1,028
639.238